Aandelen in “Productie van chirurgische apparatuur”

Aandeel	Datum	Koers	Evolutie
CollPlant Biotechnologies Ltd	2/05	6,185 USD +7,01%	+7,01%

Nieuws over “Productie van chirurgische apparatuur”

Toon enkel gratis nieuws

18/04 · Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention · Persbericht

18/04 · Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention · Persbericht

4/04 · Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE) · Persbericht

4/04 · COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE · Persbericht

4/04 · COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE · Persbericht

26/03 · COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION · Persbericht

25/03 · Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner · Persbericht

15/02 · CollPlant Issues Letter to Shareholders · Persbericht

12/02 · Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting · Persbericht

12/02 · Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe